-
FDA’s “Sentinel Initiative” Project For Monitoring Medical Product Safety: March 2009 Update
Agency Publishes Notice In March 9 Edition Of The Federal Register: Seeking Public Comment On Proposed Voluntary Survey (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2008 the FDA published a white paper, "The…
-
Warnings About Byetta Associated With Risk Of Severe Pancreatitis And Renal Failure
March 2009 Drug Safety Update Newsletter (UK) Raises Emerging Safety Issue Of Kidney-Related Side Effects From Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATE: "Diabetes Drug Byetta Linked To Kidney Problems And Cases…
-
Avandia And Actos Are In Same Class, But One Of These Diabetes Drugs Has More Safety Risks
New Study Shows Older Diabetics Were More Likely To Develop Heart Failure Or Die When Using Avandia As Opposed To Actos (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Avandia Should Be Removed from…
-
Internal Glaxo Emails Show Drug Company Was Concerned In 2007 About Avandia’s Heart Attack Risks
Senator Grassley's Report On How Glaxo Defended Avandia In Wake Of 2007 NEJM Article By Nissen And Wolski Is Expected To Be Released Soon (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2007,…
-
Sprint Fidelis Lead Wire Failures May Be On The Rise According To February 2009 Journal Article By Hauser And Hayes
Physicians Must Consider The Pros And Cons Of Surgical Removal Before Heart Device Shocks Unnecessarily Or Fails To Work When Patient Needed Shock (Posted by Tom Lamb at DrugInjuryWatch.com) On February 23, 2009 the…
-
FDA Warns About Rare Brain Infection PML Linked To Psoriasis Drug Raptiva
European Union Regulators, On Same Day, Recommend That Raptiva Be Withdrawn Because Its Risks Outweigh The Benefits ******************** Update: April 2009: Raptiva Recall In U.S. On April 8, 2009 we learned that Raptiva has been recalled due…
